4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-009479
Global President TAVR & Surg sold 8,660 shares at an average $70.00 ($606,198)
- Global President TAVR & Surg acquired 8,660 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Wood Larry L · Global President TAVR & Surg
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-10-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,660 | $45.28 | $392,096 | 222,453.71 | D |
| 2023-10-13 | Sale : show line 2 in the form 10b5-1 | −3,510 | $69.61 | $244,334 | 218,943.71 | D |
| 2023-10-13 | Sale : show line 3 in the form 10b5-1 | −5,150 | $70.26 | $361,864 | 213,793.71 | D |
| Open-market sales · 8,660 sh · avg $70.00 · $606,198 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-10-13 | Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −8,660 | $45.28 | 2025-05-16 | 8,660 | 17,318 | D |
Loading xslF345X05/doc4.xml…